Latest Biotechnology Industry News | Page 20

Proposal to amend definitions of GM for food classifications
Late-stage trial for Dimerix’s investigative Covid treatment
Voluntary standardised IP framework supported
CSL Research and Development Day 2021
IDT announces deal with Monash to produce mRNA vaccine for trial
Bright ideas sought to keep our country disease and pest free
CSL Committed to AZ COVID Vaccine
CV-19 vaccine designer joins AusBiotech 2021 line-up
CSL Requires Covid Vaccination
NSW’s first trade statement aims to double exports by 2031
Global Pipeline Tracker provides view of global pipeline and possible cell and gene therapies for Australia
Standardised agreements proposed to support commercialisation
EnGeneIC launches trial of nano cellular Covid vaccine
Cynata Therapeutics announces publication of new paper
Indian regulator approves study of Dimerix’s DMX-200 in Covid
EOI sought for new Cell and Gene Catalyst
New research shows drug repurposing is no ‘quick-fix’ in race to treat Covid
Japanese patent for Imugene’s HER-Vaxx immunotherapy
Manufacturing opportunities in cell and gene therapies highlighted in Inquiry submission
SUDA Pharmaceuticals announces ‘firm commitments’ on capital raise
US FDA grants emergency authorisation to Ellume’s COVID-19 test
AusBiotech office closure
NSW Medical Devices Fund opens
Europe grants Antisense’s ATL1102 orphan designation
Save date: AusMedtech 2021
Immutep updates on AIPAC breast cancer study and announces new trial
Queensland government back Ellume manufacturing expansion
Shaping industry’s future starts with goals
New guidance on regulatory changes for custom-made medical devices
TGA grants priority review for Telix Pharmaceuticals’ TLX591-CDx
Noxopharm completes $23m share placement
Global manufacturing survey invites Australia’s views
Telix Pharmaceuticals acquires Swiss-German counterpart
Dimerix announces a new COVID-19 study for DMX-200
AusBiotech showcases Australia’s clinical trials advantages during JP Morgan
University of Oxford/AstraZeneca Vaccine Candidate
CSL Named as One of World’s Best Employers
CSL’s Annual Research and Development Day Briefing
2021 CSL Centenary Fellowships Announced
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine
Joy Linton named as Chief Financial Officer
Industry Excellence Awards to celebrate greatest sector responses to pandemic
CSL statement on COVID19 Vaccine Manufacture
At White House Roundtable, Paul Perreault Urges People to Donate Plasma in Fight Against COVID-19
Inaccurate Report of COVID-19 Vaccine Agreement
Rare Diseases in Asia-Pacific
UQ COVID 19 Vaccine to Commence Human Trials
CSLBehring Gene Therapy Agreement with uniQure